SQZ Biotechnologies Co at Bank of America Healthcare Conference Transcript

May 10, 2022 / 09:00PM GMT
Tazeen Ahmad - BofA Securities, Inc. - Analyst

Hey, everybody, good afternoon. Welcome back to the Bank of America healthcare conference. I am Tazeen Ahmad; I'm one of the SMID biotech analysts here. It's my pleasure to have our next presenting company SQZ Biotechnologies. Sitting next to me right now is Armon Sharei, who's Founder and CEO of SQZ. This is one of our recent IPOs, so there might be a few people in the room who may not be as familiar with the company. So for that reason, I think maybe, Armon, it would be a good idea if you could just give us a two-minute overview of the company and its platform, and then we can go into some more specific questions after that.

Armon Sharei - SQZ Biotechnologies Co - CEO & Founder

Sure. Sounds good. So we weren't very creative with our naming. The company is built around squeezing cells. So essentially, during my PhD, we discovered that if you squish cells at high speeds, you can end up disrupting the membrane temporarily, such that anything that's outside the cells will diffuse into them and then the cells are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot